This is a study that is important for researchers, but one we think probably didn’t need a wide general audience in mainstream news publications.
And it left out a very important limitation of the study: It didn’t look at whether these changes had any impact on fertility.
Ample independent researchers were included, and the measured benefits of the intervention are stated clearly.
The story discusses the potential benefits in depth, which is good, but fails to quantify those benefits, which was a weak point.
Parents curious about these forthcoming treatments are likely already wondering if they’ll be affordable, but the story skirts any discussion of pricing.
The story rightly cautions that the technology is “experimental” and notes that additional research is needed. But if that’s the case, it’s not clear why this is newsworthy
Because it lacks information on costs, readers can’t answer an important question: Can I afford it?
Unfortunately the story relies more on patient anecdotes than evidence.